Together, these results characterized SMAD7 as a tumor suppressor in our model of DEN-induced HCC in mice, which is in accordance to our findings in human patient cohorts.7 The data also indicate that tumor initiation rather than tumor growth was effected by SMAD7 expression modulation. The gene discussed is SMAD7; the disease is hepatocellular carcinoma.